TRIP13 and cutaneous melanoma: Our results revealed several novel biomarkers and biological pathways that participate in the pathogenesis of cutaneous melanoma, and demonstrated the diagnostic and prognostic value of CDC45, CENPF, DTL, FANCI, GINS2, HJURP, TPX2 and TRIP13.